Appendix 3E.
Parameter | All participants |
Test result |
||||||
---|---|---|---|---|---|---|---|---|
Grayzone |
Positive |
Negative |
||||||
n | % | n | % | n | % | n | % | |
Total | 367 | 93 | 150 | 124 | ||||
Close contact with a case of COVID-19 | ||||||||
Yes | 211 | 57.5 | 56 | 60.2 | 90 | 60.0 | 65 | 52.4 |
No | 154 | 42.0 | 37 | 39.8 | 58 | 38.7 | 59 | 47.6 |
Unknown | 2 | 0.5 | 0 | 0.0 | 2 | 1.3 | 0 | 0.0 |
Main type of patient contacta | ||||||||
Daily contact with known/suspected COVID-19 patients | 88 | 24.0 | 22 | 23.7 | 40 | 26.7 | 26 | 21.0 |
Daily contact with patients without COVID-19 | 218 | 59.4 | 56 | 60.2 | 88 | 58.7 | 74 | 59.7 |
No patient contact | 61 | 16.6 | 15 | 16.1 | 22 | 14.7 | 24 | 19.4 |
Symptoms at time of previous PCR test | ||||||||
No symptoms | 7 | 1.9 | 1 | 1.1 | 3 | 2.0 | 3 | 2.4 |
Had symptoms | 358 | 97.5 | 92 | 98.9 | 145 | 96.7 | 121 | 97.6 |
Unknown | 2 | 0.5 | 0 | 0.0 | 2 | 1.3 | 0 | 0.0 |
Severity of symptoms | ||||||||
Minor symptoms | 151 | 41.1 | 38 | 43.2 | 51 | 35.2 | 62 | 51.2 |
Significant symptoms | 178 | 48.5 | 48 | 54.5 | 75 | 51.7 | 55 | 45.5 |
Severe symptoms (hospitalized) | 29 | 7.9 | 6 | 6.8 | 19 | 13.1 | 4 | 3.3 |
No. of mo since positive PCR test | ||||||||
Less than 1 | 8 | 2.2 | 1 | 1.1 | 6 | 4.0 | 1 | 0.8 |
1 | 8 | 2.2 | 0 | 0.0 | 8 | 5.3 | 0 | 0.0 |
2 | 4 | 1.1 | 0 | 0.0 | 4 | 2.7 | 0 | 0.0 |
3 | 1 | 0.3 | 0 | 0.0 | 1 | 0.7 | 0 | 0.0 |
4 | 12 | 3.3 | 2 | 2.2 | 10 | 6.7 | 0 | 0.0 |
5 | 85 | 23.2 | 28 | 30.1 | 34 | 22.7 | 23 | 18.5 |
6 | 222 | 60.5 | 54 | 58.1 | 77 | 51.3 | 91 | 73.4 |
7 | 25 | 6.8 | 8 | 8.6 | 8 | 5.3 | 9 | 7.3 |
Unknown | 2 | 0.5 | 0 | 0.0 | 2 | 1.3 | 0 | 0.0 |
No. of mo since onset of symptomsb | ||||||||
Less than 1 | 5 | 1.5 | 1 | 1.1 | 3 | 2.2 | 1 | 0.9 |
1 | 8 | 2.4 | 0 | 0.0 | 8 | 5.8 | 0 | 0.0 |
2 | 3 | 0.9 | 0 | 0.0 | 3 | 2.2 | 0 | 0.0 |
3 | 1 | 0.3 | 0 | 0.0 | 1 | 0.7 | 0 | 0.0 |
4 | 12 | 3.5 | 2 | 2.3 | 10 | 7.2 | 0 | 0.0 |
5 | 78 | 22.9 | 25 | 28.4 | 32 | 23.2 | 21 | 18.4 |
6 | 210 | 61.8 | 52 | 59.1 | 73 | 52.9 | 85 | 74.6 |
7 | 23 | 6.8 | 8 | 9.1 | 8 | 5.8 | 7 | 6.1 |
Participants were asked which one describes most of their current work.
Excludes 27 participants who were not symptomatic at the time of their positive PCR test.